Finchemo Launches New Website and Operational Phase, Driving Investments in Innovative Healthcare and Pharma Companies
Finchemo Launches New Website and Operational Phase, Driving Investments in Innovative Healthcare and Pharma Companies
“Finchemo is evolving.
We are currently redesigning our website to strengthen our global presence and better serve an increasingly competitive market.Some sections and links to our portfolio companies may be temporarily unavailable.
We apologize for any inconvenience and thank you for your understanding. We will be back online shortly with a more comprehensive and high-performance platform.”
With this banner on the finchemo.com website, we announce the start of the operational phase of our holding company Finchemo, which is starting to invest in startups and companies in the healthcare, cutting-edge diagnostics, and pharmaceutical sectors. The common denominator for the target companies will be innovative content, excellent performers, and membership or shared participation with world-class groups. This will thus initiate synergies with eXinvest of Emirates, which will finally combine its historic project development activity with distribution, true corporate assets that will increase the value of our companies and gives eXinvest a base of stable turnover and growth.
www.finchemo.com
www.exinvest.ae
Latest
-
-
26. December 2025Europe Remains the Leading Source of Pharmaceuticals for Global Export: eXinvest of Emirates Leverages Strategic Partnerships
-
24. December 2025
eXinvest of Emirates and Finchemo Thank Partners for a Year of Growth and Look Ahead to 2026 Expansion in the GCC
-
20. December 2025eXinvest of Emirates Supports Pharma & Biotech with Comprehensive Outsourced Drug Discovery Services
-
15. December 2025eXinvest of Emirates Delivers Tailor-Made Clean Rooms Across Medical, Pharmaceutical, and Industrial Sectors
-
25. October 2025API Industry Set to Reach $198 Billion by 2030: eXinvest of Emirates Strengthens Its Market Position
-
13. February 2026WHX 2026 Highlights UAE as a Global Hub for Healthcare and Pharmaceuticals: eXinvest and Finchemo Engage with Industry Leaders
-
26. December 2025Europe Remains the Leading Source of Pharmaceuticals for Global Export: eXinvest of Emirates Leverages Strategic Partnerships
-
24. December 2025
eXinvest of Emirates and Finchemo Thank Partners for a Year of Growth and Look Ahead to 2026 Expansion in the GCC
-
20. December 2025eXinvest of Emirates Supports Pharma & Biotech with Comprehensive Outsourced Drug Discovery Services
-
15. December 2025eXinvest of Emirates Delivers Tailor-Made Clean Rooms Across Medical, Pharmaceutical, and Industrial Sectors
-
25. October 2025API Industry Set to Reach $198 Billion by 2030: eXinvest of Emirates Strengthens Its Market Position